Genzyme's Carticel gets FDA nod

Biotechnology company Genzyme Corp. said today that the Food and Drug Administration approved new labeling for the company's cartilage repair product, Carticel.

The new labeling includes new safety and effectiveness information gained from a post-marketing study involving 29 clinical centers over four years, Genzyme said.

The drug was approved by the Food and Drug Administration in 1997. (AP)

•  Previous Entry
• Next Entry 

MOST E-MAILED

1. Now he's a guaranteed out
2. Together until they are ready
3. On unity, do Episcopal bishops have a prayer?
4. Angry man shoots lawn mower for not starting
5. Slam dunk for Starbucks?
6. Patient sues plastic surgeon and Mass. hospital
7. Unintended fallout of loan crisis